AA
MDCO

Ancora Advisors’s Medicines Co MDCO Stock Holding History

Ancora Advisors’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,000
Closed -$30K – 1278
2018
Q3 		$30K Buy
+1,000
New +$37.7K ﹤0.01% 1001
2017
Q1 		– Sell
-1,000
Closed -$34K – 1169
2016
Q4 		$34K Buy
+1,000
New +$35.5K ﹤0.01% 841

Other funds holding MDCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Ancora Advisors's MDCO Position: Q4 2018 in Review

Ancora Advisors sold out of Medicines Co (MDCO) in Q4 2018, closing a stake of 1,000 shares — an estimated $30K sold.

Ancora Advisors first reported a position in MDCO in Q4 2016 and held it in 2 quarters. The position peaked at $34K in Q4 2016. 188 funds tracked by Wall St. Rank hold MDCO as of Q4 2018.

  • Ancora Advisors reported no remaining Medicines Co position as of Q4 2018 after selling out during the quarter.
  • Ancora Advisors sold 1,000 Medicines Co shares in Q4 2018, an estimated $30K.
  • Ancora Advisors first reported a position in Medicines Co in Q4 2016 and held it in 2 quarters.
  • Ancora Advisors's Medicines Co position peaked at $34K in Q4 2016.
  • 188 funds tracked by Wall St. Rank held Medicines Co as of Q4 2018.

Based on Ancora Advisors's 13F filing for Q4 2018, filed 15 Feb 2019.